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Trophoblast HLA-C antigens from paternal origins, which liken the trophoblast to a semiallograft, could be presented
by the maternal APCs to the specific maternal CD4+ T helper cells, which could release various cytokines in response
to these alloantigens. On the basis of the cytokines produced, these cells can be classified in Th1, Th2 and Th17 cells.
Th1 and Th17 cells, known to be responsible for acute allograft rejection, could be involved in miscarriage and Th2 cells
together with regulatory CD4+ T cells, known to be involved in allograft tolerance, could be responsible, at least in part,
for the success of pregnancy. In this review we focus the role effector CD4+ T cells Th1, Th2 and Th17 cells on the fetal
allograft tolerance.
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One of the most remarkable aspects of reproductive
biology is the fact that a healthy woman can successfully
carry a conceptus, liken to an allograft, to full term without
rejection.
Although trophoblast does not express HLA class II
molecules, it exhibits HLA class I molecules, the
polymorphic HLA-C molecules, together with the
non-polymorphic HLA-G and HLA-E. For the presence
of paternal class I HLA-C molecules on the fetal-derived
trophoblast cells, that invade the maternal decidua
basalis, the conceptus has been considered to be a
semi-allograft. After presentation of paternal alloantigens
by maternal antigen presenting cells (APCs), the maternal
T cells specific for these alloantigens [1], could proliferate
and secrete cytokines, promoting the activation of allograft
rejection or tolerance mechanisms, respectively responsible
for pregnancy failure or fetal survival.
The juxtaposition of the placenta and decidua creates
what is refer to as the feto-maternal interface, where
placental trophoblasts and uterine lymphocytes most
obviously come into contact. It is also possible that* Correspondence: mppiccinni@hotmail.com
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to maternal blood. Thus, even though the anatomy of the
pregnant uterus would suggest that the placenta is by far
the greatest source of antigens relevant to T cell responses
during pregnancy, it remains possible that conceptus-
derived antigens are both fetal and placental in origin. The
placenta expresses its own set of tissue-specific antigens
that should be able to both prime maternal T cells and
render the conceptus susceptible to T cell-mediated attack.
The composition and function of the maternal immune
cells (8-30%) that populate the decidua are specialized not
only to foster placental development and function but also
to minimize the chances that the conceptus is attacked as
a foreign organ transplant and to combat infections
during pregnancy. The immune cell constituents of
the fetomaternal interface are during the first trimester
pregnancy primarily natural killer (NK) cells (70%), mac-
rophages (20 %) and T cells (10-20%), whereas dendritic
cells (DC), B cells and NKT cells are rare [2].
The review will try to cover the functions of CD4+
effector T cells (Th1, Th2 and Th17 cells) from the
human feto-maternal interface, given their importance
in fetal graft rejection/tolerance. The review will not
focus the T reg (CD4+, CD25+, Foxp3+) cells, although
they could be responsible for allograft tolerance because it
seem that their primary role is to dampen inflammation
to prepare implantation [3].an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Fetal specificity of decidual CD4+ T cells
Understanding the role of decidual T cells in normal and
abnormal pregnancy has been limited by an almost
complete lack of insight into how many of decidual T
cells actually have fetal specificity. In a study to address
this issue directly in humans [1], the proportion of activated
CD4 + T cells in the decidua of term pregnancies was
mildly elevated (10%) if there was a mismatch between
maternal and fetal HLA class I (HLA-C) alleles, but
not if there was a mismatch in HLA class II molecules.
Surprisingly, however, mother/child HLA-C mismatch did
not correlate with increases in the proportion of decidual
effector CD8+ T cells [1], suggesting that only decidual
CD4+ T cells have a fetal specificity. Accordingly, naive
maternal CD8+ T cells fail to be primed upon fetal antigen
exposure in the secondary lymphoid organs [4].
Fetal alloantigens presentation to T helper cells
Among the placental antigen presenting cells (APCs),
DCs exhibiting high levels of HLA class II molecules,
are the most potent activators of naive T cell responses
initiating antigen-specific T-cell responses to microbial
and transplantation antigens. Upon exposure to pathogens
and inflammatory stimuli, DCs migrate via lymphatic
vessels to lymphoid organs, where they present antigens
together with their HLA class II molecules to naive T cells
and direct T cell expansion and polarization.
As CD4+ T helper cells can recognize paternal HLA-C
molecules only if HLA-C-derived peptides are presented
by maternal APCs [1], these results are consistent with
the possibility that, T cells in pregnant women recognize
conceptus-derived antigens exclusively via indirect allore-
cognition. Accordingly human early pregnancy decidua
DC CD45+, CD40+, HLA-DR+, CD83+, CD1a + cells
were often seen in close association with CD3+ T lympho-
cytes [5]. An early study suggests that maternal CD8+ T
cells directly interact with paternal MHC class I molecules
expressed by cells of the conceptus [6]. One probable rea-
son for the lack of direct recognition of paternal MHC
molecules in mice is the fact that fetal DCs start appearing
late in gestation or maternal DCs seem to be trapped
within the decidua [7] and cannot reach the uterine drain-
ing lymph nodes. As a result of these restrictions,
conceptus-derived antigens probably reach the uterine
lymph nodes in cell-free form, to be presented by lymph
node-resident DCs. The shedding of trophoblast-derived
material into maternal blood means that placental
antigens also have access to, the spleen and non-uterine
lymph nodes, where again they are presented by maternal
DCs. After antigen presentation by DCs, effector T cells,
which leave the spleen and lymph nodes migrate via the
blood to implantation sites, where they might be able to
induce fetal demise.T cells in pregnancy
Approximately 10–20% of leukocytes in the first-trimester
human decidua are CD3 + T cells. About 30–45% of these
cells are CD4+ T cells, 45–75% CD8+ T cells and 5%
are regulatory T cells (Tregs) with immunosuppressive
properties [2].
Consequently to the presentation of paternal HLA-C
by maternal APCs the effector CD4+ T helper release
various cytokines. On the basis of the profile of cytokines
produced, they are classified in T helper (Th)1, Th2 and
Th17 cells [8,9]. As these three types of effector T helper
cells play a central role in acute allograft rejection
and tolerance, we focus the role of these 3 different
T subpopulations on fetal allograft tolerance/rejection
in human pregnancy. Fetal allograft tolerance by T
reg cells is discussed, although T reg cells have also
been reported to be responsible for alloantigens tolerance
[10], by recent multiple studies in mice suggesting that T
reg cells are stimulated by semen antigens, not spermatozoa
antigens, thus they play a role in preparing endometrium
for implantation dampening uterine inflammation, inde-
pendently of placental antigen exposure [3].
Functional activities of Th1, Th2, Th17 CD4+ cells
CD4+ Th1 cells produce interleukin (IL)-2, tumor necrosis
factor (TNF)-β and interferon (IFN)-γ and are the main
effectors of phagocyte-mediated host defense, which is
highly protective against infections sustained by intracellu-
lar pathogens. On the other hand, CD4+ Th2 cells, which
are mainly responsible for phagocyte-independent host
defense against extracellular pathogens, including nema-
todes, produce IL-4 (which together with IL-10 inhibit
several macrophage functions and together with IL-13 pro-
duced by Th2 cells, stimulates IgE antibody production)
and IL-5 (which promotes growth, differentiation and acti-
vation of eosinophils) [8]. An additional subset of CD4 + T
helper cells beyond the traditional Th1 and Th2 cells,
named Th17, which produce IL-17A, IL17F, IL-21, IL-26
and IL-22 has been identified [9]. The major roles of Th17
is the protection against extracellular bacteria and fungi, on
inflammation and on the development of some autoinflam-
matory diseases [11]. A part of human IL-17A-producing
cells were found to also produce interferon (IFN)-γ
(they are named Th17/Th1) and both Th17 and Th17/Th1
exhibit plasticity towards Th1 cells in response to IL-12
produced by APCs [11].
Role of Th1 and Th2 cells on pregnancy development
Putative Th2 and Th17 cells comprise only 5% and
2%, respectively, of first-trimester decidual CD4+ T cells,
whereas Th1 cells surprisingly comprise 5–30% of the
cells [12].
Proteins and transcripts for intragraft IL-2, IFN-γ and
the CTL-specific marker, granzyme B, have been detected
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dependent effector mechanisms play a central role in
acute allograft rejection of transplanted tissues [14].
On the other hand, the production of the Th2-type
cytokine IL-4 and IL-10, appears to be central for the
induction and the maintenance of allograft tolerance
[13]. These findings suggested, maybe in a simplistic
way, that Th1-type cytokines, that promote allograft
rejection, may compromise pregnancy, whereas the
Th2-type cytokines inhibiting the Th1 responses, promote
allograft tolerance and therefore may improve pregnancy
success. Evidence confirmed the role of Th1- and
Th2-type cytokines present at fetomaternal interface
on the development of pregnancy in mice. First, IL-4,
IL-5 and IL-10 were detectable at the fetomaternal
interface during all the period of gestation [15,16].
More TNF and IFN-γ and less IL-4 and IL-10 have
been found in the uteri of aborting matings of CBA/J
female mice with DBA/2 than in CBA/J X Balb/C
resulting in normal pregnancy outcome [17]. More
importantly, injection of TNF-α, IFN-γ or IL-2 in CBA/J
X Balb/C resulted in the increased abortion rates and
injection of IL-10 in CBA/J X Balb/C decreased abortion
rates [17]. Apparently against the Th1/Th2 paradigm in
pregnancy, there are some knock out IL-10 and IL-4-,
IL-5-, IL-9- and IL-13-deficient mice which do not affect
pregnancy rates and litter size [18]. The ridondancy
of cytokines induces sometimes to conclude quickly .
Potential roles of decidual effector CD4+ T cells have
emerged from studies on the pathogenesis of Unexplained
Recurrent Abortion (URA), with the loss of three or more
consecutive pregnancies in the first trimester of pregnancy
affects approximately 1 % of the population. In approxi-
mately 50% of cases the aetiology is unknown and the
proportion of them may be due to immune causes.
Various approaches have been adopted to underline
the role of Th1\Th2 in the aetiology of URA\success-
ful pregnancy studing peripheral blood before and at
time of miscarriage [19]. Cytokines act locally and
the measurement of T cell cytokine at the feto-
maternal interface is of greater significance. We
found a defect of IL-4 production by both CD4+ and
CD8+ T cell clones and a defect of IL-10 by CD4+ T
cell clones generated from the decidua of women
suffering from URA undergoing a spontaneous abor-
tion in comparison with women undergoing a voluntary
abortion [20].
We also found an increased production of Leukemia
inhibitory factor (LIF) [21] and macrophage-colony
stimulating factor (M-CSF) [22], (endometrial requirements
for implantation and embryo development, respectively)
by CD4+ T cell clones generated from the decidua of
women with a normal pregnancy compared to the decidua
of URA [20,23].The increased production of IL-4, IL-10, LIF and M-CSF
at the feto-maternal interface in women with normal
pregnancy has not been found at the peripheral blood
level, suggesting that this is not an inherent feature of
CD4 + T helper cells, but rather a microenvironmentally
oriented regulation. Progesterone, which, at concentra-
tions comparable to those present at the feto-maternal
interface during pregnancy, is a potent inducer of
production of IL-4 [24], but also a potent inducer of
LIF and M-CSF production by T cells [20,23] could
be at least in part responsible for a Th2 switch at
feto-maternal interface and IL-4 produced by the effector
CD4+ Th2 cells in turn promote the development of T
cells producing M-CSF and LIF important for embryo
implantation and development. Very recently, Aisemberg
[25] have confirmed these findings, demonstrating in mice
that LIF is the potential mediator of the progesterone
effect, which is essential for protecting against pregnancy
loss. Both IL-4 and IL-10 can inhibit the development
and function of Th1 and macrophages cells [26], thus
preventing the trophoblast alloantigen rejection. On the
other hand, relaxin, a polypeptide hormone predominantly
produced by the corpus luteum and decidua during
pregnancy, favors the development of T cells producing
IFN-γ [27] and may promote an adequate Th1 response
to protect the mother against dangerous intracellular
pathogens.
Recently, we found that soluble HLA-G5, a soluble iso-
form of the non classical class I molecule HLA-G, released
by trophoblast and embryo, induces IL-4 production by de-
cidual T cells in normal pregnancy. The s HLA-G5-induced
IL-4 production by decidual CD4+ T cells is dependant on
the level of expression of ILT2, the receptor for HLA-G5,
and thus on the state of activation of the decidual CD4+ T
cells by trophoblast antigens, but also on the downregula-
tion of ILT2 expression on the decidual macrophages, after
they present trophoblast antigens to the decidual CD4+
cells, which unables the macrophages to produce IL-12
(Th1 inducer) in response to HLA-G5 [28]. The role of s
HLA-G5, and more importantly, the differential ILT2
expression on uterine CD4+ T cells and macrophages could
be critical for recurrent spontaneous abortion.
Role of decidual Th17 cells on pregnancy development
Th17, has also been described as having a pathogenic
role at early stage of allograft rejection [29]. Hence, this
early evidence suggests that excessive Th17 activity may
promote abortion. Accordingly, Th17 cells has been
reported to increase, whereas T reg decrease in decidua
of patients with URA compared to healthy pregnant
women [30]. Interestingly, it seems that the number of
decidual Th17 cells is significantly higher in inevitable
abortion cases involving active genital bleeding , but not
when abortion cases do not involve active genital bleeding.
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tion of inflammation in the late stage of abortion, but
not in the early stage of abortion and thus not in
fetal rejection [31].
Very recently, we observed an associated production
of IL-4 and IL-17 by a large number of decidual CD4 +
T cells (named Th17/Th2 cells) in normal pregnancy
and at embryo implantation site, whereas Th17\Th1 cells
[11] are prevalent in URA (manuscript submitted). The
differentiation of Th17 cells into Th17/Th2 cells
already described in allergic disorders [32], seems to
be due to soluble HLA-G5 in normal human pregnancy
(manuscript submitted). Th17 cells do not show a
pathogenetic role for pregnancy, but a beneficial role,
when they also produce IL-4. Infection-related immunity
during gestation seems to be preferentially directed
towards combating extracellular microbial pathogens
with Th17-mediated immune responses in the intrauterine
environment (both fetal amniotic compartments) [33]
suggesting that Th17/Th2 cells could be essential for
the success of pregnancy, because they may promote
an adequate response to protect the mother against
dangerous extracellular pathogens and induce fetoallograft
tolerance.
Conclusion
The success of pregnancy is surely not only the result of a
tolerance towards the paternal MHC class I alloantigens,
but may also depend from many immune mechanisms,
including an adequate response required to protect the
mother against dangerous pathogens deleterious for the
pregnancy development and an adequate vascularisation
of the placenta. Cytokines produced at feto-maternal
interface form a complex regulatory network which
maintains homeostasis between the maternal immune
system and the fetus. If this delicate balance is adversely
affected, immunoregulatory mechanisms may be insuffi-
cient to restore homeostasis and this may lead to
pregnancy failure.
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